[GERD after H. pylori eradication therapy].
Kinoshita
Yoshikazu
Y
Department of Medicine II, Shimane Medical University.
Adachi
Kyoichi
K
Ishihara
Shunji
S
D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005744:Gastric Acid / Q000378:metabolism; D005764:Gastroesophageal Reflux / Q000188:drug therapy / Q000209:etiology*; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D016480:Helicobacter pylori; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D054328:Proton Pump Inhibitors; D000644:Quaternary Ammonium Compounds / Q000378:metabolism
D004791:Enzyme Inhibitors; D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors; D000644:Quaternary Ammonium Compounds